Articlenpj metabolic health and disease2025

Incretin triple agonist retatrutide (LY3437943) alleviates obesity-associated cancer progression.

Sandesh J Marathe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.